Sangamo Therapeutics, a biotech company developing treatment for genetic conditions, announced that it is laying off 162 employees, or 40% of the company’s U.S. workforce, as the company looks to restructure and focus on the creation of neurological tr…
The Health Resources and Services Administration’s definition of who qualifies as a patient under the 340B drug pricing program is too narrowly defined, a federal judge ruled Nov. 7.
A bipartisan effort to expedite the recapture of 25,000 already-issued, yet unused immigrant visas for nurses and 15,000 for physicians is garnering support from hospital groups.
Elon Musk’s Neuralink, which aims to revolutionize medicine and, frankly, humanity by installing computer chips in people’s skulls to study brain activity and restore movement in subjects with neurological disorders and paralysis, is looking for its fi…
The median operating cash flow and margins are expected to improve next year for most nonprofit hospitals, according to a Nov. 7 report from Moody’s Investor Services.
CEOs are becoming increasingly candid about environmental pressures putting their organizations — and the healthcare industry as whole — in unforgiving situations.